On the 20th anniversary of World AIDS Day, IAVI calls for people around the world to show their support for the development of an AIDS vaccine by contributing their voices to a new video commitment gallery. The world remains desperately in need of an AIDS vaccine, the best hope of ending the AIDS pandemic. READ MORE >
IAVI Opens Only Lab Solely Devoted to AIDS Vaccine Design and Development
Located in a new bioscience center in New York City, IAVI's AIDS Vaccine Design and Development Laboratory is the only facility in the world to be dedicated exclusively to the development of an AIDS vaccine. Scientists at the 36,000 square foot, state-of-the-art lab will work together with partners in academia, the private sector and government worldwide to design, compare, prioritize and advance promising AIDS vaccine strategies, with the ultimate goal of ending the global AIDS epidemic through an effective vaccine, accessible to all.
READ MORE >
HIV/AIDS: The Search for a Vaccine
Originally aired as part of BBC World’s Kill or Cure? series, this four-minute documentary features AIDS specialists, researchers, and community workers discussing the impact of HIV/AIDS on their communities and their efforts to find a solution to the epidemic. WATCH THE VIDEO DOWNLOAD THE PODCAST
What is a vaccine?
A vaccine is a substance that is introduced into the body to prevent infection or to control disease due to a
certain pathogen (any disease-causing organism, such as a virus, bacterium or parasite); the vaccine 'teaches' the
body how to defend itself against a pathogen by creating an immune response. LEARN MORE >
Why the world needs an AIDS vaccine
Despite the international community's best efforts, the HIV pandemic continues unabated. In 2006, more than
39 million people were living with HIV worldwide. Over four million people became newly infected with HIV and an
estimated 2.8 million lost their lives to AIDS. LEARN MORE >
IAVI Launches Video Commitments Project on World AIDS Day
IAVI calls for individuals from around the world to help raise global support for AIDS vaccine research and development by contributing their stories to a new video commitments gallery.
IAVI Responds to Lancet Article Modeling a Program to Combat AIDS Through Intensive Testing and Treatment
IAVI lauds the authors' approach for its focus on ending and not just mitigating the AIDS pandemic, but notes that the idea is limited in its applicability to actual circumstances.
IAVI and the St. Stephen's AIDS Trust at the Chelsea and Westminster Hospital have initiated a Phase I clinical trial in London, UK to test a prime-boost combination of two HIV vaccine candidates.
The St. Stephen's Centre at the Chelsea and Westminster Hospital in London are looking for healthy male and female volunteers between 18 and 50 years of age to participate in a new AIDS vaccine clinical trial.
Mayor Bloomberg And Other Honorees Herald Opening of IAVI’s New Design Lab
New York City Mayor Michael R. Bloomberg honored IAVI at a ribbon-cutting ceremony for its new AIDS Vaccine Design and Development Laboratory— the latest addition to IAVI's global AIDS vaccine discovery network and the only facility in the world to be dedicated exclusively to the design and development of an AIDS vaccine.
Congresswoman Yvette D. Clarke, who represents New York in the US House of Representatives, issues a supportive statement regarding the opening of IAVI’s new Design Lab in Brooklyn.
New York:
